Recently, it was proposed that PMP-containing mtDNA (such as MT-ATP6) can promote the occurrence of interstitial lung disease in SSc patients by activating the inflammatory immune response of fibroblasts [87,88]. This evidence concerns the gene MT-ATP6 and systemic sclerosis.